
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific Officer, bringing on board a seasoned leader in immunology and drug …
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer Read More